Castleview Partners’s Labcorp LH Stock Holding History

Castleview Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4	Closed	-$814	–	749
2024 Q2	$814	Buy	+4	New	+$814	﹤0.01%	825
2022 Q3	–	Sell	-233	Closed	-$1.37K	–	689
2022 Q2	$1.37K	Buy	233 +41	+21%	+$8.74K	﹤0.01%	661
2022 Q1	$43K	Sell	192 -57,960	-100%	-$13.6M	0.03%	366
2021 Q4	$159	Buy	+58,152	New	+$14.4M	﹤0.01%	725
2021 Q2	$151K	Buy	+638	New	+$145K	0.07%	242

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castleview Partners's LH Position: Q3 2024 in Review

Castleview Partners sold out of Labcorp (LH) in Q3 2024, closing a stake of 4 shares — an estimated $814 sold.

Castleview Partners first reported a position in LH in Q2 2021 and held it in 5 quarters. The position peaked at $151K in Q2 2021. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

Castleview Partners reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
Castleview Partners sold 4 Labcorp shares in Q3 2024, an estimated $814.
Castleview Partners first reported a position in Labcorp in Q2 2021 and held it in 5 quarters.
Castleview Partners's Labcorp position peaked at $151K in Q2 2021.
918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.